Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
File(s) Lancet_378_9809_2011_panel.pdf (30.74 KB) Lancet_378_9809_2011.pdf (234.85 KB)
Supporting information
Accepted version
Author(s)
Type
Journal Article
Date Issued
2011-12-17
ISSN
0140-6736
Publisher
ELSEVIER SCIENCE INC
Start Page
2081
End Page
2087
Journal / Book Title
LANCET
Volume
378
Issue
9809
Copyright Statement
Copyright © 2011 Elsevier Ltd. All rights reserved. NOTICE: this is the author’s version of a work that was accepted for publication in the Lancet. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in the Lancet, 378(9809), 2011. DOI:10.1016/S0140-6736(11)61049-0
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000298293600029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Publication Status
Published
